These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 8245377)

  • 1. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional therapy for glycogen storage diseases.
    Heller S; Worona L; Consuelo A
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S15-21. PubMed ID: 18667910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage disease: recommendations for treatment.
    Fernandes J; Leonard JV; Moses SW; Odièvre M; di Rocco M; Schaub J; Smit GP; Ullrich K; Durand P
    Eur J Pediatr; 1988 Apr; 147(3):226-8. PubMed ID: 3292244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of glycogen storage diseases].
    Endres WT
    Padiatr Padol; 1991; 26(1):19-24. PubMed ID: 1905390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cornstarch therapy in a patient with type III glycogen storage disease.
    Borowitz SM; Greene HL
    J Pediatr Gastroenterol Nutr; 1987; 6(4):631-4. PubMed ID: 3480949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.
    Roscher A; Patel J; Hewson S; Nagy L; Feigenbaum A; Kronick J; Raiman J; Schulze A; Siriwardena K; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2014 Nov; 113(3):171-6. PubMed ID: 25266922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
    Grünert SC; Hannibal L; Spiekerkoetter U
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing and managing type I and type III glycogen storage diseases.
    Mahoney KG
    MCN Am J Matern Child Nurs; 1984; 9(5):338-42. PubMed ID: 6433137
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic ultrasound findings in the glycogen storage diseases.
    Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C
    Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen storage disease type I and III and pyruvate carboxylase deficiency: results of long-term treatment with uncooked cornstarch.
    Ullrich K; Schmidt H; van Teeffelen-Heithoff A
    Acta Paediatr Scand; 1988 Jul; 77(4):531-6. PubMed ID: 3134793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for glycogen storage disease types I, III, and IV.
    Matern D; Starzl TE; Arnaout W; Barnard J; Bynon JS; Dhawan A; Emond J; Haagsma EB; Hug G; Lachaux A; Smit GP; Chen YT
    Eur J Pediatr; 1999 Dec; 158 Suppl 2(Suppl 2):S43-8. PubMed ID: 10603098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cornstarch therapy in type III glycogen-storage disease.
    Gremse DA; Bucuvalas JC; Balistreri WF
    Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
    Shin YS
    Semin Pediatr Neurol; 2006 Jun; 13(2):115-20. PubMed ID: 17027861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.
    Slonim AE; Weisberg C; Benke P; Evans OB; Burr IM
    Ann Neurol; 1982 Apr; 11(4):420-2. PubMed ID: 7049057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.
    Nakai A; Shigematsu Y; Takano T; Kikawa Y; Sudo M
    Eur J Pediatr; 1994 Aug; 153(8):581-3. PubMed ID: 7957405
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.